A randomized double-blind placebo-controlled trial of combined escitalopram and memantine for older adults with major depression and subjective memory …

H Lavretsky, KT Laird, B Krause-Sorio… - The American Journal of …, 2020 - Elsevier
Objective Geriatric depression is difficult to treat and frequently accompanied by cognitive
complaints that increase risk for dementia. New treatment strategies targeting both …

A Randomized Double-Blind Placebo-Controlled Trial of Combined Escitalopram and Memantine for Older Adults With Major Depression and Subjective Memory …

H Lavretsky, KT Laird, B Krause-Sorio… - The American Journal …, 2019 - europepmc.org
Objective Geriatric depression is difficult to treat and frequently accompanied by cognitive
complaints that increase risk for dementia. New treatment strategies targeting both …

A randomized double-blind placebo-controlled trial of combined escitalopram and memantine for older adults with major depression and subjective memory …

H Lavretsky, KT Laird, B Krause-Sorio… - The American Journal …, 2020 - psycnet.apa.org
Objective: Geriatric depression is difficult to treat and frequently accompanied by cognitive
complaints that increase risk for dementia. New treatment strategies targeting both …

[引用][C] A Randomized Double-Blind Placebo-Controlled Trial of Combined Escitalopram and Memantine for Older Adults With Major Depression and Subjective …

H Lavretsky, KT Laird, B Krause-Sorio… - The American Journal …, 2020 - cir.nii.ac.jp
A Randomized Double-Blind Placebo-Controlled Trial of Combined Escitalopram and
Memantine for Older Adults With Major Depression and Subjective Memory Complaints | CiNii …

A Randomized Double-Blind Placebo-Controlled Trial of Combined Escitalopram and Memantine for Older Adults With Major Depression and Subjective Memory …

H Lavretsky, KT Laird, B Krause-Sorio… - … American Journal of …, 2020 - Am Assoc Geria Psych
Objective Geriatric depression is difficult to treat and frequently accompanied by cognitive
complaints that increase risk for dementia. New treatment strategies targeting both …

A Randomized Double-Blind Placebo-Controlled Trial of Combined Escitalopram and Memantine for Older Adults With Major Depression and Subjective Memory …

H Lavretsky, KT Laird, B Krause-Sorio… - American Journal of …, 2020 - escholarship.org
ObjectiveGeriatric depression is difficult to treat and frequently accompanied by cognitive
complaints that increase risk for dementia. New treatment strategies targeting both …

[HTML][HTML] A randomized double-blind placebo-controlled trial of combined escitalopram and memantine for older adults with major depression and subjective memory …

H Lavretsky, KT Laird, B Krause-Sorio… - The American journal …, 2020 - ncbi.nlm.nih.gov
Objectives Geriatric depression is difficult to treat and frequently accompanied by cognitive
complaints that increase risk for dementia. New treatment strategies targeting both …

A Randomized Double-Blind Placebo-Controlled Trial of Combined Escitalopram and Memantine for Older Adults With Major Depression and Subjective Memory …

H Lavretsky, KT Laird… - American Journal …, 2020 - mahidol.elsevierpure.com
Objective: Geriatric depression is difficult to treat and frequently accompanied by cognitive
complaints that increase risk for dementia. New treatment strategies targeting both …

A Randomized Double-Blind Placebo-Controlled Trial of Combined Escitalopram and Memantine for Older Adults With Major Depression and Subjective Memory …

H Lavretsky, KT Laird… - … journal of geriatric …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective Geriatric depression is difficult to treat and frequently accompanied by cognitive
complaints that increase risk for dementia. New treatment strategies targeting both …